What makes Dana-Farber/Boston Children's a world-renowned pediatric cancer center?Through our shared resources, we offer unmatched expertise in pediatric cancer and blood disorders. And you don’t have to take our word for it. In 2018, U.S. News & World Report ranked
our five-year cancer survival rate as excellent for acute lymphoblastic leukemia, acute myeloid leukemia, and neuroblastoma, and the Center for
International Blood and Marrow Transplant Research (CIBMTR) determined that we
were the only pediatric stem cell transplant center in the U.S. to exceed the
expected survival rate for transplant patients in 2017.
Who benefits? The thousands of children, adolescents, and young adults we treat each year.